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We have explored in detail the determinants of specificity for the
hydrolysis by human tissue kallikrein (hK
"
) of substrates con-
taining the Phe–Phe amino acid pair, after which hK
"
cleaves
kallistatin (human kallikrein-binding protein), a specific serpin
for this protease, as well as somatostatin 1–14. Internally
quenched fluorogenic peptides were synthesized with the general
structure Abz-peptidyl-EDDnp [Abz, o-aminobenzoic acid;
EDDnp, N-(2,4-dinitrophenyl)ethylenediamine], based on the
natural reactive-centre loop sequence of kallistatin from P
*
to
P«
"$
, and the kinetic parameters of their hydrolysis by hK
"
were
determined. All these peptides were cleaved after the Phe–Phe
pair. For comparison, we have also examined peptides containing
the reactive-centre loop sequences of human protein-C inhibitor
(PCI) and rat kallikrein-binding protein, which were hydrolysed
after Phe–Arg and Leu–Lys bonds, respectively. Hybrid peptides
INTRODUCTION
Human tissue kallikrein (hK
"
) is one member of a family of three
closely related serine proteases [1,2], which also includes two
enzymes expressed in prostate, namely, prostate-specific antigen
(hK
$
or PSA) and a trypsin-like enzyme, hK
#
. The genes that
correspond to these proteins, hKLK1, hKLK2 and hKLK3 [3],
have been mapped to chromosome 19 [4]. hK
"
is the only tissue
kallikrein with already-established functions, which include re-
lease of Lys-bradykinin (kallidin) in several inflammatory pro-
cesses, such as arthritis, asthma and rhinitis [5–8], and the
processing of hormone and other peptide precursors [1,2].
Attempts to identify natural substrates for hK
#
and hK
$
have
shown that coagulum-forming proteins from seminal plasma,
semenogelins and fibronectin are cleaved at Arg sites by hK
#
and
at Tyr, Phe or Leu sites by hK
$
[9,10].
hK
"
and the cognate enzymes in mammals release Lys-
bradykinin from bovine and human kininogen by cleaving at
Met–Lys and Arg–Ser bonds [11]. The only exception known so
far is rat tissue kallikrein (rK
"
), which cleaves a Lys–Arg bond
and releases bradykinin from bovine and rat kininogens [12,13].
The efficiency of cleavage at the Met–Lys bond by hK
"
is
dependent on the extension of the substrates, as demonstrated
with internally quenched fluorescent peptides with the sequence
of human kininogen [14,15]. hK
"
can also hydrolyse after a pair
of phenylalanines, for example in the reactive-centre loop of
hK
"
-binding protein, in a specific serpin for tissue kallikrein
called kallistatin [16,17], as well as in somatostatin [18]. Although
hK
"
possesses significant similarity with trypsin, the crystal
structures of human and porcine tissue kallikrein [19,20] show
Abbreviations used: PCI, human protein-C inhibitor ; hK1, human tissue kallikrein ; Abz, o-aminobenzoic acid ; EDDnp, N-(2,4-dinitrophenyl)-
ethylenediamine; pNA, p-nitroanilide ; MCA, methylcoumarine amide; MALDI-TOF, matrix-assisted laser desorption ionization–time-of-flight.
1 To whom correspondence should be addressed (e-mail juliano.biof!epm.br).
containing kallistatin–PCI sequences showed that the efficiency
of hK
"
activity on the peptides containing kallistatin and PCI
sequences depended on both the nature of the P
"
amino acid as
well as on residues at the P- and P«-sides. Moreover, we have
made systematic modifications on the hydrophobic pair Phe–Phe,
and on Lys and Ile at the P
$
and P
%
positions according to the
peptide substrate, Abz-AIKFFSRQ-EDDnp. All together, we
concluded that tissue kallikrein was very effective on short
substrates that are cleaved after the Phe–Arg pair ; however,
hydrolysis after Phe–Phe or other hydrophobic pairs of amino
acids was more restrictive, requiring additional enzyme–substrate
interaction and}or particular substrate conformations.
Key words: fluorescent substrate, kallistatin, peptide, protease,
serpin.
that their S
"
sites (see Schechter and Berger nomenclature, [21])
are enlarged, mainly owing to the insertion of an additional
residue, Pro-219, which is in the cis configuration. This unique
feature of tissue kallikrein allows its S
"
subsite to accept Arg as
well as the larger and hydrophobic side chain of Phe.
hK
"
binds to a
"
-antitripsin, the most abundant circulating
proteinase inhibitor and an archetypal member of the serpin
superfamily [22] ; this interaction is slow when compared with
interaction with human protein-C inhibitor (PCI) [23] and with
kallistatin [24]. These two serpins contain Phe–Arg and Phe–Phe,
respectively, at positions P
#
and P
"
. Kallistatin is very specific for
hK
"
, in contrast with PCI, which has a broader inhibitory activity
against other serine proteases [16,17]. It was demonstrated
previously that the peptides derived from the reactive-centre loop
of kallistatin and PCI were substrate for hK
"
[18,25].
The development of efficient and particularly specific inhibitors
for hK
"
requires a detailed evaluation of hK
"
’s unique substrate
specificity that accepts substrates with Phe at the P
"
position. In
order to obtain this information, we synthesized internally
quenched fluorogenic peptides with the general structure
Abz-peptidyl-Gln-EDDnp [Abz, o-aminobenzoic acid; EDDnp,
N-(2,4-dinitrophenyl)ethylenediamine] based on the reactive-
centre loop sequence of kallistatin and PCI, and determined the
kinetic parameters of their hydrolysis by hK
"
. The effects of
peptide chain length, of the amino acids Arg or Phe at the P
"
site
and of hybrid kallistatin–PCI sequences on the susceptibility to
hK
"
were examined as well.
Finally, it has been demonstrated that in the crystal structure
of the complex hirustasin–porcine tissue kallikrein the inhibitor
occupies the S
%
–S«
#
sites of protease-extended-binding site [26].
# 1999 Biochemical Society
474 D. C. Pimenta and others
In order to explore in detail the substrate specificity of hK
"
in
these subsites, we used the peptide Abz-AIKFFSAQ-EDDnp as
a lead substrate, which contains the reactive-centre loop sequence
of kallistatin from P
%
to P«
$
, and synthesized different com-
binations of the hydrophobic amino acid pair at P
#
and P
"
. We
also performed systematic modifications on Lys and Ile at the P
$
and P
%
positions.
MATERIALS AND METHODS
Enzymes
hK
"
was purified from pooled urine according to Shimamoto et
al. [27]. The molar concentrations of enzyme solutions were
determined by active-site titration with 4-nitrophenyl-4-guani-
dinobenzoate [28].
Synthetic substrates
All the intramolecularly quenched fluorogenic peptides contained
EDDnp attached to glutamine, a necessary result of the solid-
phase peptide-synthesis strategy employed, the details of which
are provided elsewhere [29]. An automated bench-top simul-
taneous multiple solid-phase peptide synthesizer (PSSM 8 system
from Shimadzu) was used for the solid-phase synthesis of all the
peptides by the fluoren-9-ylmethoxycarbonyl (Fmoc) procedure.
Chromogenic peptidyl-p-nitroanilide (peptidyl-pNA) and fluor-
escent peptidyl-methylcoumarine amide (peptidyl-MCA) sub-
strates, used to titrate the enzymes and to calibrate the equip-
ments, were synthesized as described previously [30]. Amino acid
analyses were carried out in a Beckman 6300 amino acid analyser
following hydrolysis in 6 M HCl with 5% phenol at 110 °C for
48 h. The final deprotected peptides were purified by semi-
preparative HPLC using an Econosil C
")
column (10 lm mesh;
22.5 mm‹250 mm) and a two-solvent system: (A) trifluoroacetic
acid}H
#
O (1:1000) ; and (B) trifluoroacetic acid}acetonitrile}
H
#
O (1:900:100). The column was allowed to elute at a flow rate
of 5 ml}min with either a 10–50% gradient of solvent B over
30 min or a 30–60% gradiant of solvent B over 45 min. Analytical
HPLC was performed using a binary HPLC system from
Shimadzu with a SPD-10AV Shimadzu UV}visible-light detector
and a Shimadzu RF-535 fluorescence detector, coupled to an
Ultrasphere C
")
column (5 lm mesh; 4.6‹150 mm), which was
allowed to elute with solvent systems A
"
(H
$
PO
%
}H
#
O, 1:1000)
and B
"
(acetonitrile}H
#
O}H
$
PO
%
, 900:100:1) at a flow rate of
1.7 ml}min and a 10–80% gradient of solvent B
"
over 15 min.
The HPLC column eluates were monitored by their absorbance
at 220 nm and by fluorescence emission at 420 nm, following
excitation at 320 nm. The molecular masses and purities of
synthesized peptides were checked by matrix-assisted laser de-
sorption ionization–time-of-flight (MALDI-TOF) MS (TofSpec-
E, Micromass).
Fluorimetric enzyme assay
Hydrolysis of the fluorogenic peptidyl substrates at 37 °C in
20 mM Tris}HCl, pH 9.0, containing 1 mM EDTA, 10% DMSO
and 0.1% Triton X-100, was followed by measuring the fluor-
escence at k
emission
420 nm and k
excitation
320 nm in a Hitachi F-
2000 spectrofluorometer. The 1-cm path-length cuvette con-
taining 2 ml of the substrate solution was placed in a thermo-
statically controlled cell compartment for 5 min before the
enzyme solution was added and the increase in fluorescence with
time was recorded continuously for 10 min. The slope was
converted into mol of substrate hydrolysed}min based on the
fluorescence curves of standard peptide solutions before and
Figure 1 Hydrolysis of Abz-AIKFFSAQTNRHILRFNR-EDDnp (peptide IV) by
hK1
The kinetic parameters obtained for this assay were Km 0.031 lM and Vmax 7.4 nM/min (Table
1). Insert, the data were fitted into a Eadie–Hofstee plot, which yielded the values of Km as
0.030 lM and of Vmax as 7.3 nM/min. For this experiment, substrate concentration ranged as
shown and enzyme concentration was 0.09 nM.
after total enzymic hydrolysis. Their concentration in solution
could be determined from the fluorescence obtained following
total tryptic hydrolysis for 2 h. The concentration of a standard
solution of Abz-Phe-Arg-pNA (in 0.2 M NaOH) was calculated
based on the amount of p-nitroaniline liberated by trypsin as
measured by the absorbance at 405 nm. The enzyme concen-
trations for initial rate determinations were chosen at a level
intended to hydrolyse less than 5% of the substrate present [31].
The kinetic parameters were calculated by non-linear regression
according to Wilkinson [32]. In order to check the reliability of K
m
values lower than 0.05 lM, Eadie–Hofstee plots were used as
shown in Figure 1.
The K
i
values for competitive-inhibition assays of the peptides
were determined according to Nicklin and Barrett [33].
Determination of bonds cleaved
The bonds cleaved were identified by isolation of the fragments
by HPLC, and the retention times of the fluorescent Abz-
containing fragments were compared with authentic synthetic
sequences and}or by molecular mass, which was determined by
MALDI-TOF MS.
RESULTS
Hydrolysis by hK1 of internally quenched fluorescent peptides with
reactive-centre loop sequences of human serpins
The internally quenched fluorescent peptides containing the
reactive-centre loop sequence of serpins were assayed as sub-
strates of hK
"
(Table 1). The serpins used were human kallistatin
(peptides I–IV), PCI (peptides V and VI) and rat kallikrein-
binding protein (peptide VII). The substrate structures and the
kinetic data for the hydrolysis of all susceptible peptides to hK
"
are also presented in Table 1. HPLC and mass spectrometric
analyses showed that the substrates with the kallistatin sequence
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Table 1 Kinetic parameters for hydrolysis by hK1 of internally quenched fluorescent peptides with reactive-centre loop sequences of some human serpins
Hydrolysis conditions : 20 mM Tris/HCl/1 mM EDTA/10% DMSO/0.1% Triton X-100 buffer, at pH 9.0 and 37 °C. Results are presented as means‡S.E. $ indicates the position of cleavage.
Abbreviations : HKBP : human kallikrein-binding protein (kallistatin) ; RKBP : rat kallikrein-binding protein.
No. Peptide Sequence of Abz-peptidyl-Q-EDDnp Km (lM) kcat (s−
1) kcat/Km (mM−
1[s−1)
I HKBP350–361 A-T-T-F-A-I-K-F-F $ S-A 2.23‡0.09 0.50‡0.01 224
II HKBP354–361 A-I-K-F-F $ S-A 1.79‡0.11 0.54‡0.01 302
III HKBP354–364 A-I-K-F-F $ S-A-Q-T-N-R 0.72‡0.04 1.71‡0.01 2375
IV HKBP354–371 A-I-K-F-F $ S-A-Q-T-N-R-H-I-L-R-F-N-R 0.031‡0.004 1.21‡0.02 40333
V PCI354–363 I-F-T-F-R $ S-A-R-L-N 0.045‡0.004 0.91‡0.02 18200
VI PCI354–371 I-F-T-F-R $ S-A-R-L-N-S-Q-R-L-V-F-N-R 0.046‡0.003 2.29‡0.03 45800
VII RKBP354–371 T-A-A-L-K $ S-L-P-Q-T-I-P-L-L-N-F-N-R 1.99‡0.09 0.17‡0.0.1 85
Figure 2 Competitive inhibitory assay of Abz-AIKFFSAQTNRHILRFNR-
EDDnp (peptide IV)
Peptide IV was assayed as a competitive inhibitor over the hydrolytic activity of hK1 on the
substrate (D)Pro-Phe-Phe-MCA (Km 70 lM, kcat 12.5 s−
1, [18]) according to the method
described by Nicklin and Barrett [33]. For this experiment, 30 lM (D)Pro-Phe-Phe-MCA and
5 pM hK1were used.
were cleaved at the Phe–Ser bond, and those with PCI and rat
kallikrein-binding protein sequences were hydrolysed at Arg–Ser
and Lys–Ser bonds, respectively.
The kinetic data for hydrolysis of peptides I–IV show that a C-
terminal extension from the cleavage site of peptides with the
kallistatin sequence significantly improved the hydrolytic
efficiency by increasing the k
cat
and decreasing the K
m
values.
However, peptide IV, with a larger C-terminal extension, was
hydrolysed with similar k
cat
value to peptide III, but with a low,
sub-micromolar, K
m
value. The reliability of this very low K
m
value was then verified by transforming the kinetic data into an
Eadie–Hofstee plot (Figure 1, insert), which confirmed the kinetic
parameters obtained. Furthermore, the K
i
value of 30 nM
obtained for inhibition by peptide IV of (d)Pro-Phe-Phe-MCA
hydrolysis (Figure 2) confirms the high affinity of hK
"
for this
peptide.
The substrates with the PCI sequence (peptides V and VI) are
hydrolysed by hK
"
with similar, and also low, K
m
values. The
extension on the C-terminal side (peptide VI) increased the k
cat
value 2-fold in comparisonwith peptideV.The kinetic parameters
for hydrolysis of peptide containing rat kallikrein-binding protein
sequence from residues 354–371 (peptide VII) showed that the
resulting substrate was poorly hydrolysed by hK
"
.
The effect of the nature of the amino acid at the primary
specificity site (P
"
) in both kallistatin and PCI peptide sequences
was examined by substituting Phe with Arg in the substrates
containing kallistatin sequences (peptides VIII and IX); the
opposite substitution was made in the substrates containing PCI
sequences (peptides X and XI; Table 2). All of these four
peptides were hydrolysed with k
cat
}K
m
values lower than the
parent substrates (compare peptides III with VIII, IV with IX, V
with X and VI with XI). Therefore, these results indicate that the
efficiency of hydrolysis after Phe–Phe or Phe–Arg pairs by hK
"
is dependent on the nature of the other residues, probably on
both sides of these dipeptides.
In order to explore these specificity requirements on the P«
side, we synthesized a hybrid peptide containing kallistatin
sequence (Ala-Ile-Lys-Phe-Phe) followed by PCI sequence (Ser-
Ala-Gln-Thr-Asn-Ser), shown in Table 2 as peptide XII. We also
synthesized two other analogues of this peptide, one with a
substitution of Arg by Gln (peptide XII) and the other with
a substitution of Arg and Leu by Gln and Thr, respectively
(peptide XIII). These substitutions gradually transformed the
hybrid substrate (peptide XII) into one containing only kallistatin
sequence (peptide III) ; the kinetic parameters for the hydrolysis
of these peptides are shown in Table 2. The hybrid peptide was
the poorest substrate for hK
"
in this series, being hydrolysed with
the lowest k
cat
}K
m
value (due essentially to the high K
m
value).
The restoration of Gln and}or Thr in peptides XIII and XIV
reduced the K
m
value by 1 order of magnitude. However, the
highest k
cat
}K
m
values were observed with peptide III, which
contained amino acids only from kallistatin. These results suggest
that Gln at P«
$
and Arg at P«
’
assume significant roles in
determining the specificity of hK
"
for cleavage after the Phe–Phe
pair in kallistatin.
Hydrolysis of peptides of the Abz-AIKX2X1SRQ-EDDnp series
The importance of the Phe–Phe pair at the P
"
and P
#
positions
for efficient hydrolysis by hK
"
was evaluated by synthesizing a
series of peptides containing one or both Phe residues substituted
for other hydrophobic amino acids in Abz-AIKFFSRQ-EDDnp
(peptide XV; Table 3). This peptide, with an Arg residue at the
P«
#
position instead of Ala (peptide II), was chosen as the lead
substrate because it is hydrolysed with a high k
cat
and k
cat
}K
m
,
and exhibits a low K
m
value. We made this choice in order to
increase the possibility of detection of minimal hydrolysis of the
worst substrates of this series. In addition, the higher solubility
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Table 2 Kinetic parameters for hydrolysis by hK1 of internally quenched fluorescent peptides with reactive-centre loop sequences of kallistatin and PCI,
as well as hybrid peptides
Hydrolysis conditions were as for Table 1. Results are presented as means‡S.E. $ indicates the position of cleavage. Abbreviation : HKBP, hK1-binding protein (kallistatin). Underlined amino
acids in peptides XII–XIV indicate the segment that pertains to PCI sequence.
No. Peptide (with mutation shown) Sequence of Abz-peptidyl-Q-EDDnp Km (lM) kcat (s−
1) kcat/Km (mM−
1[s−1)
VIII HKBP354–364, F! R358 A-I-K-F-R $ S-A-Q-T-N-R 0.27‡0.02 0.46‡0.02 1704
IX HKBP354–371, F! R358 A-I-K-F-R $ S-A-Q-T-N-R-H-I-L-R-F-N-R 0.098‡0.006 0.37‡0.02 3700
X PCI354–363, R! F358 I-F-T-F-F $ S-A-R-L-N – – 130‡6*
XI PCI354–371, R! F358 I-F-T-F-F $ S-A-R-L-N-S-Q-R-L-V-F-N-R – – 1848‡55*
XII HKBP354–360PCI361–364 A-I-K-F-F $ S-A-R-L-N-S 11.94‡0.24 0.32‡0.01 27
XIII HKBP354–361PCI362–364 A-I-K-F-F $ S-A-Q-L-N-S 1.19‡0.03 0.48‡0.02 403
XIV HKBP354–364, R! S364 A-I-K-F-F $ S-A-Q-T-N-S 1.09‡0.05 0.16‡0.01 146
III HKBP354–364 A-I-K-F-F $ S-A-Q-T-N-R 0.72‡0.04 1.71‡0.01 2375
* Determined in pseudo first-order condition, due to low solubility of the peptides.
Table 3 Kinetic parameters for hydrolysis by hK1 of internally quenched fluorescent peptides with reactive-centre loop sequences of kallistatin containing
some modifications at P1 and P2 positions with hydrophobic amino acids
Hydrolysis conditions were as in Table 1. Results are presented as means‡S.E. $ indicates the position of cleavage. Underlined residues represent those that have been modified in a given
series.
No. Sequence of Abz-peptidyl-Q-EDDnp Km (lM) kcat (s−
1) kcat/Km (mM−
1[s−1)
XV A-I-K-F-F $ S-R 0.36‡0.01 3.33‡0.15 9250
XVI A-I-K-M-M $ S-R 1.35‡0.09 0.28‡0.01 207
XVII A-I-K-L-L $ S-R 1.63‡0.12 0.14‡0.01 86
XVIII A-I-K-M-F $ S-R 0.80‡0.06 0.65‡0.01 813
XIX A-I-K-L-F $ S-R 0.35‡0.01 0.74‡0.02 2114
XX A-I-K-F-M $ S-R 0.68‡0.02 0.15‡0.01 221
XXI A-I-K-L-M $ S-R 0.36‡0.01 0.18‡0.01 500
XXII A-I-K-M-L $ S-R 5.37‡0.14 0.39‡0.01 73
XXIII* A-I-K-I-I-S-R – – –
XXIV* A-I-K-V-V-S-R – – –
XXV* A-I-K-W-W-S-R – – –
XXVI* A-I-K-Y-Y-S-R – – –
* Substrates not hydrolysed at enzyme concentration higher than 5 nM.
in water due to the presence of Arg was desirable for obtaining
an appropriate concentration range in a systematic study.
The highest specificity constant (k
cat
}K
m
) among the hydro-
phobic amino acid pairs was observed for the hydrolysis
of the lead substrate (peptide XV), which contained the
Phe–Phe pair, followed by peptides XIX and XVIII, which
also contained Phe at position P
"
. The peptide with the
Met–Met pair was a better substrate than the one containing
Leu–Leu (compare peptides XVI and XVII). To explore
the susceptibility of peptides containing a Leu–Leu pair we
synthesized two peptides containing the a
"
-antichymotrypsin
reactive-centre loop: Abz-ATAVKITLLSA-EDDnp and Abz-
KITLLSALVETRTIVRFNR-EDDnp. These peptides were
completely resistant to hK
"
. All other hydrophobic pairs, Ile–Ile,
Val–Val, Trp–Trp and Tyr–Tyr (peptides XXIII–XXVI), were
not hydrolysed by hK
"
. The combination of Phe, Met and Leu
was also examined. The substrate with Leu–Met (peptide XXI)
was more susceptible to hK
"
than that with Met–Leu (peptide
XXII), which was hydrolysed with the highest K
m
value of this
series. In contrast, the lowest values for K
m
were obtained with
the Phe–Phe-, Leu–Met- and Leu–Phe-containing peptides
(peptides XV, XXI and XIX). It is noteworthy that somatostatin
and human kininogen were also hydrolysed by hK
"
after the
dipeptides Phe–Phe and Leu–Met, respectively [15,18].
Hydrolysis of peptides of the series Abz-AIX3FFSRQ-EDDnp and
Abz-AX4KFFSRQ-EDDnp
The modification at the P
$
position, which corresponds to the
series Abz-AIX
$
FFSRQ-EDDnp, resulted in substrates that were
all susceptible to hK
"
; however, the lead peptide of this series (X
flLys, peptide XV) was the best-hydrolysed substrate (Table 4).
Higher K
m
values were observed with Ser, Thr, Asn and Gln
(peptides XXXI–XXXIV), indicating an unfavourable effect on
the substrate binding of hydroxyl and carboxamide functions.
Ala-, Leu-, Glu- and Pro-containing substrates were hydrolysed
with lower K
m
values. However, despite this increase in the
substrate affinity, a negative effect was observed for their
hydrolysis, due to lower k
cat
values (peptides XXVII–XXX). It is
worthwhile to note that the substrate with Thr at P
$
(peptide
XXXII), which is also present in PCI at the same position, was
hydrolysed with the second-best k
cat
value, followed by Ser
(peptide XXXI).
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Table 4 Kinetic parameters for hydrolysis by hK1 of internally quenched fluorescent peptides with reactive-centre loop sequences of kallistatin and some
modifications at the P3 position
Hydrolysis conditions were as for Table 1. Results are presented as means‡S.E. $ indicates the position of cleavage. Underlined residues represent those that have been modified in a given
series.
No. Sequence of Abz-peptidyl-Q-EDDnp Km (lM) kcat (s−
1) kcat/Km (mM−
1[s−1)
XV A-I-K-F-F $ S-R 0.36‡0.01 3.33‡0.15 9250
XXVII A-I-A-F-F $ S-R 0.29‡0.01 0.60‡0.02 2069
XXVIII A-I-L-F-F $ S-R 0.14‡0.01 0.18‡0.01 1289
XXIX A-I-E-F-F $ S-R 0.60‡0.02 0.58‡0.01 967
XXX A-I-P-F-F $ S-R 0.40‡0.02 0.06‡0.01 150
XXXI A-I-S-F-F $ S-R 3.52‡0.09 1.49‡0.06 423
XXXII A-I-T-F-F $ S-R 2.36‡0.11 2.06‡0.09 873
XXXIII A-I-Q-F-F $ S-R 1.21‡0.08 1.19‡0.05 983
XXXIV A-I-N-F-F $ S-R 1.40‡0.09 0.38‡0.02 271
Table 5 Kinetic parameters for hydrolysis by hK1 of internally quenched fluorescent peptides with reactive-centre loop sequences of kallistatin and some
modifications at the P4 position
Hydrolysis conditions as described in Table 1. Results are presented as means‡S.E. $ indicates the position of cleavage. Underlined residues represent those that have been modified in a given
series.
No. Sequence of Abz-peptidyl-Q-EDDnp Km (lM) kcat (s−
1) kcat/Km (mM−
1[s−1)
XV A-I-K-F-F $ S-R 0.36‡0.01 3.33‡0.15 9250
XXXV A-V-K-F-F $ S-R 1.10‡0.05 1.52‡0.08 1381
XXXVI A-L-K-F-F $ S-R 0.12‡0.01 0.07‡0.01 583
XXXVII A-A-K-F-F $ S-R 1.40‡0.02 0.59‡0.02 421
XXXVIII A-P-K-F-F $ S-R 0.31‡0.01 0.43‡0.01 1387
XXXIX A-E-K-F-F $ S-R 20.0‡1.22 0.96‡0.03 48
XL A-Q-K-F-F $ S-R 2.00‡0.05 1.33‡0.05 665
XLI A-N-K-F-F $ S-R 1.50‡0.06 0.37‡0.01 247
XLII A-T-K-F-F $ S-R 3.80‡0.09 2.46‡0.02 647
XLIII A-S-K-F-F $ S-R 1.10‡0.05 0.85‡0.02 772
XLIV A-K-K-F-F $ S-R 0.36‡0.02 0.14‡0.01 388
The modifications at the P
%
position demonstrated that the
hydrolytic activity of hK
"
on the series Abz-AX
%
KFFSRQ-
EDDnp was quite sensitive to the S
%
–P
%
interaction. Again, the
lead substrate (peptide XV; Table 5), with Ile at the P
%
position,
was hydrolysed with the highest k
cat
}K
m
value in the series.
However, it is particularly noteworthy that the k
cat
}K
m
value for
this substrate was 7 and 17 times higher than for the substrates
with Val (peptide XXXV) or Leu (peptide XXXVI) respectively,
due to the sensitivity to the structure of aliphatic side chain of the
amino acids. In addition, the latter substrates were hydrolysed
with the lowest k
cat
and K
m
values in the series. The substrates
with Pro and Lys were hydrolysed with K
m
values similar to that
of the lead compound, but with significantly lower k
cat
values
(compare peptide XV with peptides XXXVIII and XLIV). All
other substitutions, Ala, Glu, Gln, Asn, Thr and Ser (peptides
XXXVII and XXXIX–XLIII) were hydrolysed with higher K
m
and lower k
cat
values than the lead substrate (peptide XV). The
worst substrate was obtained with Glu (peptide XXXIX), indi-
cating the very unfavourable effect of a carboxyl negative charge
at the P
%
position.
DISCUSSION
The development of specific inhibitors for tissue kallikreins and
for other kallikrein-like enzymes depends on detailed information
about their substrate–subsite interactions. Some of these deter-
minants were identified in previous studies on the hydrolysis by
human, pig, horse and rat tissue kallikreins of the arginyl and
lysyl bonds in synthetic substrates. The following observations
have been reported: (i) Arg in position P
"
is preferred over Lys
[34] ; (ii) the Phe side chain binds best to the enzyme’s S
#
subsite
[21,34,35] ; (iii) d-amino acid residues at P
$
interact favourably
with human and horse kallikreins [35,36] ; and (iv) Pro in P«
#
impairs the cleavage by horse and pig, but not by rat, tissue
kallikrein, whereas Arg in P«
"
or P«
#
increases the efficiency of
cleavage by all three kallikreins [31,37–39].
Met and Phe were the only hydrophobic amino acids so far
described at which hK
"
was able to cleave [14,15,18]. The
specificity to Phe is higher than to Met because hK
"
was able to
hydrolyse small chromogenic or fluorogenic peptides, such as
(d)Pro-Phe-Phe-pNa or (d)Pro-Phe-Phe-MCA [15,18], in con-
trast with the resistance of the Met–X linkage in short synthetic
peptides [40]. The results shown in this paper demonstrate that
the efficiency of hK
"
hydrolytic activity is higher after Phe–Phe
in comparison with other hydrophobic pairs assayed and is
significantly influenced by the substrate size as well as by the
nature of amino acids at secondary subsites.
All the synthetic peptides based on the sequence of the reactive-
centre loop of human kallistatin were recognized as substrates by
hK
"
. The values of the kinetic parameters obtained were de-
pendent on the size of the C-terminal extensions. The significant
decrease in K
m
values for hydrolysis of peptides I–IV, to 30 nM
for peptide IV, indicates that the C-terminal amino acids of the
extended substrate (residues P«
"
–P«
"$
) profoundly influenced
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binding to hK
"
. A similar behaviour, but with a less dramatic
reduction in K
m
values, was also observed for the cleavage of the
Met–Lys bond by hK
"
in substrates with the human kininogen
sequence [14], which also required larger sequences for a more
efficient hydrolysis. On the other hand, the extension of substrate
on the N-terminal side of the scissile bond beyond P
&
(peptide I ;
Table 1) seems to have no effect on its hydrolysis by hK
"
. This
contrasts with the hydrolysis of the Met–Lys bond in substrates
with human kininogen sequence that is apparently sensitive to
substrate extension up to P
(
[14]. Therefore, it seems that the
requirements of secondary specificity for cleavage of substrates
after hydrophobic amino acid pairs by hK
"
depend on the nature
of the amino acid pairs.
The K
m
values for the hydrolysis of peptides V and VI were
alike and as low as the value for peptide IV. On the other hand,
the k
cat
value for the longer PCI-loop peptide (IX) was twice as
high. Therefore, extension of the C-terminus in peptides V and
VI did not have the same effect on K
m
as observed with the
hydrolysis of peptides III and IV. In general, short peptides were
efficiently hydrolysed by hK
"
after a Phe–Arg pair, and the
obtained kinetic parameters indicate that fewer amino acids were
required to interact at S« subsites of the enzyme than those with
Phe–Phe at the same positions. A similar, but not-so-pronounced,
behaviour was observed for the hydrolysis of Arg–Ser and
Met–Lys bonds in substrates containing human kininogen se-
quence [14]. These results suggested that the electrostatic
guanidinium–carboxylate interaction of Arg from substrate and
Asp-189 at the S
"
protease pocket provides most of the required
energy for enzyme–substrate interaction. On the other hand, in
substrates containing Phe at P
"
, the energy for binding is
supplemented by the secondary subsite interactions. This view is
in accordance with the kinetic parameters for the hydrolysis of
Abz-AIKFRSR-EDDnp (K
m
0.05 lM, k
cat
2.07 s−") compared
with those obtained with Abz-AIKFFSR-EDDnp (peptide XV;
Table 3).
The efficiency of the substrate hydrolysis by hK
"
after Phe–Phe
or Phe–Arg amino acid pairs is highly dependent on the nature
of the residues on both sides of these pairs. The substrates with
the kallistatin sequence, but with Phe-358 substituted by Arg
(peptides VIII and IX), and peptides X and XI, derived from PCI
sequence, in which Arg-358 was replaced by Phe, were hydrolysed
with k
cat
}K
m
values (Table 2) significantly lower than those of
parent peptides (III, IV, V and VI; Table 1). Therefore, the
limited proteolytic activity of hK
"
is also extended to its arginyl-
hydrolase function. Accordingly, the Arg–Phe bonds in peptide
IV as well as in Abz-HILRFNRQ-EDDnp were resistant to
hydrolysis to hK
"
, although the sequences of these peptides have
all the known requirements to be substrates of this enzyme. On
the other hand, we observed that peptide Abz-VIAGRSLNP-
NRVTFK $ANR-EDDnp, which contains the reactive-centre
loop of antithrombin III, is hydrolysed at the Lys–Ala bond
(indicated by the arrow) with a K
m
of 0.06 lM and a k
cat
of
1.26 s−".
We further explored the specificity requirements for hydrolysis
after the Phe–Phe pair using three approaches. The first was the
synthesis of a hybrid peptide, containing kallistatin and PCI
sequences, and its analogues, gradually turning the PCI segment
into the kallistatin sequence. It was clear from the analysis of the
kinetic parameters for hydrolysis of these substrates (peptides
XII–XIV) that Gln at P«
$
and Arg at P«
’
play significant roles in
the interaction and catalytic processes of hK
"
on the kallistatin
reactive-centre loop. The second approach was to verify if other
hydrophobic pairs of amino acids in the sequence of kallistatin
could be hydrolysed by hK
"
, and the third approach was a
systematic variation at the P
$
and P
%
sites of the kallistatin
reactive loop. The parent substrates were most susceptible to
hK
"
, as determined from the lowest K
m
and the highest k
cat
values
of the series with substitution on the Phe–Phe pair (Tables 1, 2
and 3). In addition, P
$
and P
%
substrate sites also take part in the
determination of specificity (Tables 4 and 5) for the hydrolysis
after the Phe–Phe pair and, again, as in the lead substrate, Lys
and Ile were the best residues at the P
$
and P
%
positions. These
results, together with the previously described hydrolysis by hK
"
of somatostatin at the Phe–Trp bond (shown by an arrow;
AGCKNFF $WKTFTSC), and the resistance of substance P
(RPKPQQFFGLM-NH
#
) and of the human insulin b-chain (…
G#!ERGFFYTPKA$!-COOH) [18], lead us to the hypothesis
that the efficiency of hydrolysis after Phe–Phe by hK
"
does not
depend on the presence of specific amino acids at both sides of
this amino acid pair. Indeed, the small chromogenic or fluoro-
genic peptides (d)Pro-Phe-Phe-pNa or (d)Pro-Phe-Phe-MCA
are hydrolysed by hK
"
with k
cat
}K
m
values of 462 and 179
mM−"[s−" respectively [15,18]. In addition, the presence of such
diverse amino acids as Lys, Leu and Pro at the P
$
and P
%
positions resulted in substrates cleaved with the lowest K
m
values. On the other hand, since the cleavage after Phe–Phe was
more restricted in larger peptides, it is reasonable to speculate
that this particular hydrolytic activity of hK
"
depends on
secondary structures that the substrate could adopt. This situ-
ation would be similar to the previously described dependency of
hydrolytic activity of THIMET, a thiol-metallo-protease that
processes biologically active peptides [41,42], on general peptide
structure rather than absolute sequence. Moreover, limited
proteolysis seems to be a process in which dynamics, and not
only the enzyme}substrate ratio, play a role in determining
whether a particular cleavage will be observed. Nevertheless, the
actual proteolytic cleavage of a peptide bond still depends on
the prime determinants of specificity of the enzyme and on the
flexibility and exposure of the putative scissile bond [43].
In conclusion, it is noteworthy that tissue kallikrein is very
effective on substrates that are cleaved after the Phe–Arg pair ;
however, the hydrolysis after Phe–Phe, or other pairs of hydro-
phobic amino acids, is much more restricted, requiring secondary
enzyme–substrate bindings and}or preferred sets of conform-
ations of the substrates. Accordingly, hK
"
is more specific for
hydrolysis after the Phe–Phe pair, and kallistatin, which contains
Phe–Phe, is a more specific serpin for tissue kallikrein than PCI,
which contains Phe–Arg [16,17,20].
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